Atrys Health SA ATRY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €2.88
- Day Range
- €2.87–2.88
- 52-Week Range
- €2.77–5.90
- Bid/Ask
- — / —
- Market Cap
- €217.93 Mil
- Volume/Avg
- 2,436 / 46,213
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.10
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,061
- Website
- http://www.atryshealth.com
Comparables
Valuation
|
Metric
|
ATRY
|
688656
|
603122
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 399.80 | 53.87 |
Price/Book Value | 0.75 | 1.82 | 2.02 |
Price/Sales | 1.10 | 4.04 | 2.13 |
Price/Cash Flow | 9,260.45 | 17.13 | 33.78 |
Price/Earnings
ATRY
688656
603122
Financial Strength
|
Metric
|
ATRY
|
688656
|
603122
|
|---|---|---|---|
Quick Ratio | 0.90 | 1.81 | 3.38 |
Current Ratio | 0.97 | 2.68 | 4.39 |
Interest Coverage | −0.04 | 16.56 | 10.59 |
Quick Ratio
ATRY
688656
603122
Profitability
|
Metric
|
ATRY
|
688656
|
603122
|
|---|---|---|---|
Return on Assets (Normalized) | −3.63% | 0.40% | 3.06% |
Return on Equity (Normalized) | −7.80% | 0.47% | 4.01% |
Return on Invested Capital (Normalized) | 0.88% | 0.56% | 3.41% |
Return on Assets
ATRY
688656
603122
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qylstlhnrl | Qhs | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Bcpqfbyq | Tvzdc | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Gyvhmdprn | Kfsdfk | $99.5 Bil | |
MRNA
| Moderna Inc | Vgktqksh | Qlng | $38.8 Bil | |
ARGX
| argenx SE ADR | Bhwmfmm | Xmj | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Vjnqjmyh | Yxvhn | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Pvhhtnmlv | Bzvnw | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bfjmgzhld | Jmxkpyr | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Pklyjhsbq | Sqjvyhd | $12.5 Bil | |
INCY
| Incyte Corp | Tglkrdnm | Pcfrbdh | $11.6 Bil |